AiCure Named to the 2018 AI 100, Highlighting Advancements in Artificial Intelligence for Patient Monitoring

This year's list was culled from 1000+ applications and looks even more impressive.  These are companies using artificial intelligence in industries from drug discovery and cybersecurity to robotics and legal tech.  I'm happy that CB Insights is able to shine a light on the founders and companies that will revolutionize these industries and look forward to seeing what they do in 2018 and beyond." said CB Insights CEO Anand Sanwal.

Adam Hanina, co-founder and CEO of AiCure, commented: "We are delighted to be recognized as one of the world's 100 most innovative AI companies. AiCure is tackling the multibillion dollar problem of failed trials and poor clinical outcomes. Our visual recognition platform is creating enormous impact and value through intelligent observation."

The CB Insights research team selected the AI 100 companies based on criteria, examining company-submitted data and the company's Mosaic Score. The Mosaic Score, based on CB Insights' National Science Foundation-funded algorithm, measures the overall health and growth potential of private companies. Through this evidence-based, statistically-driven approach, the Mosaic Score can help predict a company's momentum, market health and financial viability.

Companies such as Flatiron Health, Babylon, and Freenome joined AiCure in being recognized for their innovative technology in front of an audience of 400 senior innovation executives from around the world and news outlets including The Financial Times, CNBC, Reuters, Bloomberg and the Washington Post.

About AiCure
AiCure's intelligent medical assistant, IMA, leverages a visual recognition platform to monitor patient progress. IMA provides visual dose confirmation, interactive patient support and engagement, and visual diagnostic capabilities. With almost 100 patents awarded or pending and funding from leading institutional investors and the National Institutes of Health, the platform has been validated to improve patient behavior in randomized controlled trials. AiCure is revolutionizing drug development and clinical care by ensuring that high quality treatments reach the patients that need them most. Intelligent observation leads to better care.

For more information contact:
Press Officer
AiCure
[email protected] 
800-570-0448

Quick facts on the AI 100:

• These 100 emerging private companies have raised $6.6B across 99 deals in 2017.
• Applications of their technology include breakthroughs in fintech, digital health, auto tech, robotics, and much more.
• More than 1,000 companies were nominated or applied and only 9% were selected.
• Eleven AI 100 companies have reached a valuation of $1B or more.
• Thirty-three companies on the list were also on the list for 2017, with 67 new companies making it for 2018.
• Nine countries are represented among the AI 100 companies.

The AI 100 Companies (in alphabetical order):

About CB Insights
Our team builds technology that helps corporations guess less and win more. We aggregate and analyze terabytes of data and use machine learning, algorithms and data visualization to help corporations replace the three Gs (Google searches, gut instinct and guys with MBAs*) so they can answer massive strategic questions using probability not punditry.

*We have MBAs.

Contact:
Farrah Kim, Senior Public Relations & Communications Manager
[email protected] 
212-292-3148

For more information about the AI 100, visit:
https://www.cbinsights.com/research-ai100 

To learn more about A-ha!, go here: http://events.cbinsights.com/aha

SOURCE AiCure

Related Links

http://www.aicure.com